A Post Marketing Survey Study to Evaluate the Safety and Effectiveness of Prezista

Regulatory Post Marketing Surveillance of Prezista 400mg Tablet

The purpose of this study is to assess the safety data of darunavir in a natural clinical practice.

This is a non-interventional (a scientific study to make a clear and easy understanding of the cause and effect relationship), prospective (in which the participants are first identified and then followed forward as time passes), consecutive survey for collecting safety and efficacy data of darunavir in treatment of Acquired Immune Deficiency Syndrome (AIDS) in a natural clinical practice.

Inclusion Criteria:

• Patients who are prescribed with darunavir for treatment of Acquired Immune Deficiency Syndrome (AIDS)

Exclusion Criteria:

• Known hypersensitivity to Prezista
• Prezista coadministered with medicinal products that are highly dependent on CYP3A for clearance